USPTO serial 79263355
Serial No. 79263355
Reviewed by CopyMark Law Group
Reg. 6082373Status 707Renewal
- Filing date
- Status date
- Registration date
- Jun 23, 2020
- Examiner
- MAIHOS, JESSIE ANDREA
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79263355?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, N.W.10th FloorWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, in particular DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides, in particular antibodies and tumour markers; cell-based immunotherapeutic treatment, namely, by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular scientific research and development in the field of medical [ and veterinary ] diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, screening for pharmaceutically active compounds; [ scientific research and development of diagnostic methods and test processes; ] research and development of supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific study and research in the field of medicine; scientific research and development for medical [ and veterinary ] purposes; scientific study and research in the field of pharmaceuticals [ ; medical and pharmaceutical consultation, namely, testing, analysis and evaluation of goods and services of others to determine conformity with certification standards ] | ACTIVE | — |
| 044 | Medical services; [ medical care and consultancy; pharmaceutical and medical consultancy; ] information and advisory services in the healthcare field; preparation of reports relating to medical and pharmaceutical matters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioNTech SE
- Other trademarks owned by BioNTech SE
- Other trademarks owned by BioNTech SE
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Oct 21, 2026 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Oct 19, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 10, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 27, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 15, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 15, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 15, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 15, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 15, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 23, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 15, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 2, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 13, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 13, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 23, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 23, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 7, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 7, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 18, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 18, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 18, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 18, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 13, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 24, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 27, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 6, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 16, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 15, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jul 29, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |